# FORECAST QUALITY ASSESSMENT REPORT

## Authored by

**Model/Agent:** Opus 4.6

---

## Critical Issues Summary

| Issue | Severity | Location | Description |
|-------|----------|----------|-------------|
| S1-1 and S1-2 outside views heavily inflated by pipeline speculation | High | S1-1, S1-2 | Both Sonnet 4.5 instances used pipeline candidates (Bhutan "on track...soon") to inflate their outside view predictions to 67% and 58% respectively, despite the outside view being intended to rely on base rates and reference classes rather than inside-view-style pipeline intelligence. This contaminates the two-stage design. |
| Question URL scrape failed | Medium | Research | The primary resolution URL (WHO malaria-free page) failed to scrape, missing the most directly relevant data source -- the current state of the WHO page at question open. |
| S2-3 (GPT-5.2) inside view much higher than all others | Medium | S2-3 | GPT-5.2 produced 42% while all other forecasters converged to 22-27%, creating a 20pp outlier that pulled the aggregate upward. The reasoning lacked strong justification for this divergence. |
| AskNews deep research hit rate limit | Low | Research | AskNews deep research failed with a 403 usage-limit error; however, standard AskNews returned 17 articles, so impact was limited. |
| AskNews returned many irrelevant articles | Low | Research | Several AskNews articles were entirely off-topic (Ukraine driver training, India UIDAI biometrics, cholera vaccines), wasting context window space and adding noise. |

**Severity definitions:**
- **Critical**: Fundamentally compromises the forecast
- **High**: Significantly affects forecast quality
- **Medium**: Notable weakness but core forecast intact
- **Low**: Minor issue

---

## Summary

- **Question ID:** 42045
- **Question Title:** Will WHO publish an update indicating at least one additional country or territory has been certified malaria-free, before May 1, 2026?
- **Question Type:** binary
- **Forecast Date:** 2026-02-10
- **Resolution Date:** 2026-05-01
- **Forecast Window:** 80 days
- **Final Prediction:** 28.2%
- **Step 2 Predictions:** S2-1: 27%, S2-2: 25%, S2-3: 42%, S2-4: 22%, S2-5: 25%
- **Spread:** 20pp (22% to 42%)
- **Total Cost:** $0.73
- **Duration:** 233 seconds
- **One-sentence quality assessment:** Solid ensemble performance with good base rate analysis and appropriate skepticism about the short 80-day window, though the GPT-5.2 outlier at 42% and contamination of outside views with pipeline intelligence weakened the two-stage structure.

---

## 1. Research Query Analysis: Historical vs. Current

### Research Tools by Stage

| Tool | Historical (Outside View) | Current (Inside View) | Actually Used? |
|------|--------------------------|----------------------|----------------|
| Google (Serper) | Yes | Yes | Yes (both) |
| Google News | Yes | Yes | Yes (both) |
| Agentic Search (Agent) | Yes | No | Yes (historical only; 3 steps) |
| AskNews | No | Yes | Yes (current only; deep research failed with 403) |
| FRED | If economic/financial | No | N/A (not relevant) |
| yFinance | If stocks/securities | No | N/A (not relevant) |
| Google Trends | If relevant (MC only) | No | N/A (binary question) |
| Question URL Scraping | Yes (prepended) | No | Attempted but failed (0 results from WHO page) |

### Query Discreteness

**Historical Queries** (tools: Google, Google News, Agent):
1. `candidate countries malaria-free certification WHO` (Google) -- 2 results
2. `WHO malaria-free certification 2025` (Google News) -- 3 results
3. `Retrieve WHO press releases...list all malaria-free certifications since 2015 with month of announcement and calculate average yearly frequency.` (Agent) -- 3 steps, 1 report

**Current Queries** (tools: Google, Google News, AskNews):
1. `WHO malaria-free certification 2026` (Google) -- 3 results
2. `WHO certifies country malaria-free 2026` (Google News) -- 3 results
3. `What WHO press releases since January 2026 mention new or pending malaria-free country certifications?` (AskNews) -- 17 articles

**Assessment Table:**

| Aspect | Historical | Current |
|--------|------------|---------|
| Temporal focus | Historical certification patterns 2015-2025, pipeline candidates | 2026-specific announcements and recent news |
| Content type | WHO reports, certification history, process documentation | News articles, health ministry announcements, WHO press releases |
| Tools used | Google, Google News, Agent | Google, Google News, AskNews |
| Unique contribution | Base rate calculation (1.55/year), pipeline identification (Bhutan, Malaysia, Turkey) | Confirmation that no 2026 certifications announced yet, Cabo Verde re-emergence concern |

**Analysis:**
- Query sets are well-differentiated. Historical queries targeted the certification pipeline and base rate establishment; current queries targeted whether any 2026 certifications had already occurred.
- The Agent query was ambitious and well-designed, requesting both pipeline intelligence and historical frequency computation. Unlike the failed Agent in the 42038 forecast, this Agent delivered a genuinely useful report: a complete list of 17 certifications since 2015 with approximate months, the 1.55/year average, and identification of Bhutan and Malaysia as pipeline candidates. Agent took only 3 steps (vs. the maximum 7), demonstrating efficient execution.
- The Question URL scrape failure was unfortunate -- the WHO malaria-free certification page is the primary resolution source and would have provided the definitive baseline count at question open.
- AskNews returned 17 articles but many were irrelevant (Ukraine driver training, India UIDAI biometrics, cholera vaccines, norovirus outbreaks). Only about 5-6 articles were directly relevant.
- Critical information successfully surfaced: historical certification rate (1.55/year), recent certifications (2024-2025), pipeline candidates (Bhutan, Malaysia), certification process requirements (3 years zero cases + TAG-MEC review), and the absence of any 2026 certification announcements.
- Critical information gap: No specific TAG-MEC meeting schedule for 2026 was found, which would have been highly informative for timing.

### Do Research Outputs Offer Forecasts?

Research outputs were appropriately factual. The Agent report stayed focused on retrieving and compiling factual data (certification dates, pipeline status) without offering probability estimates. AskNews articles reported on WHO data and expert statements without forecasting certification timing. Overall, research appropriately informed without forecasting.

### Research Quality Summary

- **Key information successfully surfaced:**
  - Historical certification rate: 17 certifications in 2015-2025 = 1.55/year
  - Month-level timing of historical certifications (some inferred)
  - Pipeline candidates: Bhutan "on track...soon" (Dec 2025 report), Malaysia (7 years zero cases)
  - Current count: 47 countries + 1 territory as of Feb 10, 2026
  - Most recent certifications: Egypt, Georgia, Suriname, Timor-Leste
  - No 2026 certifications announced as of Feb 10, 2026
  - WHO certification process: 3 consecutive years zero cases + government request + TAG-MEC review
- **Critical information missed:**
  - WHO malaria-free page content at question open (scrape failed)
  - TAG-MEC meeting schedule for 2026
  - Turkey certification status (mentioned in 2024 report as having submitted request, outcome unknown)
- **Source quality by tool:**
  - Google/Google News results: Good. Contagion Live, Statista, Africa Renewal, WIPO blog all provided useful corroborating data.
  - Agent report: Strong. Efficiently compiled a comprehensive historical certification list with dates and pipeline intelligence in only 3 steps.
  - AskNews articles: Mixed. High volume (17 articles) but low signal-to-noise ratio.

---

## 2. Step 1 (Outside View) Analysis

### Step 1 Output Assessments

#### Step 1 Output 1 (Sonnet 4.5)

- **Source Analysis:** Thorough evaluation of all 5 sources with quality ratings. Correctly identifies Contagion Live as current-day reporting, notes count discrepancies explained by timing. 4/4
- **Reference Class Selection:** Identifies 3 reference classes. Including pipeline candidates in the "outside view" blurs the outside/inside view boundary. 3/4
- **Timeframe Analysis:** Correctly states 80 days = 2.7 months = 22% of year. Notes Q1 certification pattern (29%). 4/4
- **Base Rate Derivation:** Starts from 35% Poisson-based rate, then adds large adjustments for Bhutan signal (+25%), Q1 pattern (+10%), multiple candidates (+10%). The additive approach is methodologically problematic and the pipeline adjustments belong in the inside view. Final 67% is significantly higher than the 25-29% pure base rate. 2/4

- **Score:** 13/16

---

#### Step 1 Output 2 (Sonnet 4.5)

- **Source Analysis:** Thorough with quality tags. Good source reconciliation showing progression from 44+1 to 47+1. 4/4
- **Reference Class Selection:** Identifies 4 reference classes including recent acceleration (2023-2025: 2.33/year). Still mixes pipeline candidates into reference class selection. 3/4
- **Timeframe Analysis:** Detailed month-by-month historical breakdown. Calculates Jan-Apr certifications: 6 in 8 years = 0.75/year. 4/4
- **Base Rate Derivation:** More structured than S1-1. Calculates component probabilities for Bhutan (~45%), Malaysia/other (~15%). Still incorporates pipeline intelligence, but more transparent. 3/4

- **Score:** 14/16

---

#### Step 1 Output 3 (GPT-5.2)

- **Source Analysis:** Concise but covers all sources. Good fact/opinion separation. 3/4
- **Reference Class Selection:** Selects window-matched reference class (Feb 10-Apr 30) as most suitable, cross-checked against annual frequency. Does NOT incorporate pipeline intelligence. Most methodologically sound approach. 4/4
- **Timeframe Analysis:** Performs both Poisson (lambda = 0.34, P(>=1) = 29%) and empirical (3/11 years = 27%) calculations. Highly consistent. 4/4
- **Base Rate Derivation:** Clear and mathematically sound. Adjusts downward for page update latency. Final: 24.8%. Most principled derivation in the ensemble. 4/4

- **Score:** 15/16

---

#### Step 1 Output 4 (o3)

- **Source Analysis:** Covers all sources concisely. Good fact/opinion separation. 3/4
- **Reference Class Selection:** Selects Jan-Apr window (5/11 years = 45%) with Poisson cross-check. The 45% figure uses a broader window definition than S1-3's 27%. 3/4
- **Timeframe Analysis:** Good but some date attributions may be imprecise. 3/4
- **Base Rate Derivation:** Shrinkage approach (mean of 45% and 30% = 37.5%), then -8pp for uncertainty. Final: 37%. Methodologically sound. 3/4

- **Score:** 12/16

---

#### Step 1 Output 5 (o3)

- **Source Analysis:** Concise, covers all sources with quality notes. 3/4
- **Reference Class Selection:** Selects 80-day window as most tailored. Explicitly avoids pipeline intelligence. 4/4
- **Timeframe Analysis:** Both empirical (3/11 = 27%) and Poisson (29%) calculations. Saturation concern from 2025's above-average certifications. 4/4
- **Base Rate Derivation:** Clear: 28% base minus 2pp saturation = 26%. Well-reasoned and mathematically sound. 4/4

- **Score:** 15/16

---

### Step 1 Summary

| Output | Model | Prediction | Score | Key Strength | Key Weakness |
|--------|-------|------------|-------|--------------|--------------|
| S1-1 | Sonnet 4.5 | 67% | 13/16 | Thorough source analysis | Pipeline intelligence contaminated outside view |
| S1-2 | Sonnet 4.5 | 58% | 14/16 | Good historical month-by-month breakdown | Pipeline candidates in outside view |
| S1-3 | GPT-5.2 | 24.8% | 15/16 | Most principled derivation; proper outside/inside separation | Slightly concise on source analysis |
| S1-4 | o3 | 37% | 12/16 | Good shrinkage methodology | Reference class definition wider than optimal |
| S1-5 | o3 | 26% | 15/16 | Excellent twin-method validation; saturation adjustment | Minor: slightly conservative |

---

## 3. Step 2 (Inside View) Analysis

### Cross-Pollination Flow

| Step 2 Instance | Model | Receives Step 1 From | Step 1 Input |
|-----------------|-------|---------------------|--------------|
| S2-1 | Sonnet 4.5 | S1-1 (self-model) | 67% |
| S2-2 | Sonnet 4.5 | S1-4 (o3) | 37% |
| S2-3 | GPT-5.2 | S1-2 (Sonnet 4.5) | 58% |
| S2-4 | o3 | S1-3 (GPT-5.2) | 24.8% |
| S2-5 | o3 | S1-5 (self-model) | 26% |

### Step 2 Output Assessments

#### Step 2 Output 1 (Sonnet 4.5): receives S1-1

- **Evidence Weighting:** Excellent. Crucially identifies "No current news of pending certifications" as STRONG NEGATIVE evidence -- the most important insight in the entire ensemble. 4/4
- **Update from Base Rate:** Input: 67% -> Output: 27%, Delta = -40pp. Dramatic and well-justified correction. Explicitly recalculates from pure base rate, recognizing outside view was inappropriately inflated. 4/4
- **Timeframe Sensitivity:** Addresses halved (25-30%) and doubled (50-55%) scenarios with specific reasoning. 4/4
- **Calibration Checklist:** Complete with all 7 items addressed meaningfully. 4/4

- **Score:** 16/16

---

#### Step 2 Output 2 (Sonnet 4.5): receives S1-4

- **Evidence Weighting:** Good. Correctly identifies absence of current pipeline evidence as strong negative. Adds temporal disadvantage observation. 3/4
- **Update from Base Rate:** Input: 37% -> Output: 25%, Delta = -12pp. Well-justified adjustments. 4/4
- **Timeframe Sensitivity:** Good analysis with halved/doubled scenarios. 3/4
- **Calibration Checklist:** All items present and meaningful. 4/4

- **Score:** 14/16

---

#### Step 2 Output 3 (GPT-5.2): receives S1-2

- **Evidence Weighting:** Uses framework but less structured. Somewhat impressionistic. 3/4
- **Update from Base Rate:** Input: 58% -> Output: 42%, Delta = -16pp. Direction correct but magnitude insufficient. S2-3 ends 15-20pp above all others. Speculative World Malaria Day reasoning. 2/4
- **Timeframe Sensitivity:** Good analysis with specific scenario reasoning. 3/4
- **Calibration Checklist:** All items addressed. 3/4

- **Score:** 11/16

---

#### Step 2 Output 4 (o3): receives S1-3

- **Evidence Weighting:** Concise but effective. Notes pipeline candidates (Saudi Arabia, Belize) that differ from research-sourced candidates. 3/4
- **Update from Base Rate:** Input: 24.8% -> Output: 22%, Delta = -2.8pp. Appropriate given well-calibrated outside view. 4/4
- **Timeframe Sensitivity:** Brief but adequate. 3/4
- **Calibration Checklist:** All items addressed. Belize error (already certified 2023) noted. 3/4

- **Score:** 13/16

---

#### Step 2 Output 5 (o3): receives S1-5

- **Evidence Weighting:** Concise. Good nuance about recent cadence showing "active pipeline." 3/4
- **Update from Base Rate:** Input: 26% -> Output: 25%, Delta = -1pp. Appropriate given well-calibrated outside view. 4/4
- **Timeframe Sensitivity:** Addresses halved (15%) and doubled (low-50%). 3/4
- **Calibration Checklist:** All items addressed. 3/4

- **Score:** 13/16

---

### Step 2 Summary

| Output | Model | S1 Input | Final | Delta | Score | Update Justified? |
|--------|-------|----------|-------|-------|-------|-------------------|
| S2-1 | Sonnet 4.5 | 67% | 27% | -40pp | 16/16 | Yes (correction of inflated S1) |
| S2-2 | Sonnet 4.5 | 37% | 25% | -12pp | 14/16 | Yes |
| S2-3 | GPT-5.2 | 58% | 42% | -16pp | 11/16 | Partial (insufficient correction) |
| S2-4 | o3 | 24.8% | 22% | -2.8pp | 13/16 | Yes |
| S2-5 | o3 | 26% | 25% | -1pp | 13/16 | Yes |

---

## 4. Cross-Pollination Effectiveness

### Assessment

- **S2-2 (Sonnet 4.5 receiving S1-4/o3 at 37%):** Good engagement. Final 25% is close to S2-1's 27%, demonstrating Sonnet 4.5 converges regardless of cross-model input.

- **S2-3 (GPT-5.2 receiving S1-2/Sonnet 4.5 at 58%):** Counterproductive. S2-3 only corrected to 42%, becoming a significant outlier. GPT-5.2 appears more susceptible to anchoring bias from cross-pollinated inputs.

- **S2-4 (o3 receiving S1-3/GPT-5.2 at 24.8%):** Received the most principled outside view and made a very small adjustment to 22%. Cross-pollination effectively preserved quality.

- **Same-model instances (S2-1 at 67%->27%, S2-5 at 26%->25%):** Despite receiving very different S1 inputs, both arrived at nearly identical final probabilities, demonstrating convergent reasoning from current evidence.

- **Net effect:** Cross-pollination had limited positive impact. Four forecasters converged to 22-27% regardless of starting outside view, driven by strong current evidence. The one case where it may have caused harm was S2-3, which anchored too heavily on the inflated S1-2 input.

---

## 5. Factual Accuracy & Comprehension

### Question Understanding

- All instances correctly understood the resolution criteria: the WHO page must show at least one new country/territory with certification year "2026" that was not present at question open.
- All correctly identified the forecast timeframe: February 10 to May 1, 2026 = 80 days.
- All correctly assessed the current status: 47 countries + 1 territory certified, with no 2026 certifications announced as of Feb 10, 2026.

### Factual Consensus

Facts all/most outputs correctly identified:
1. Current count: 47 countries + 1 territory certified malaria-free as of Feb 10, 2026
2. Most recent certifications: Egypt (2024), Cabo Verde (2024), Georgia (2025), Suriname (2025), Timor-Leste (2025)
3. Historical certification rate: ~1.55 per year (2015-2025)
4. Certification requires 3 consecutive years of zero indigenous cases + government request + TAG-MEC review
5. No 2026 certifications had been announced as of the forecast date

### Factual Errors or Ambiguities

| Output | Error/Ambiguity | Description | Impact |
|--------|-----------------|-------------|--------|
| S2-4 | Belize cited as pipeline candidate | States "Saudi Arabia & Belize reportedly fulfil zero-case criterion" but Belize was already certified in June 2023 (this fact is even in the Agent report). | Low |
| S1-4 | Egypt date discrepancy | References Egypt's certification as Oct 2024 (from Africa Renewal) and Dec 2024 (from Agent report). Both dates appear in sources. | Low |
| S2-4 | Saudi Arabia as pipeline candidate | Cites Saudi Arabia based on an ISID blog noting zero indigenous cases, not from WHO pipeline communications. Evidence base is thin. | Low |

### Hallucinations

No clear hallucinations detected. All key facts are corroborated by research sources. S2-4's mention of Saudi Arabia as a pipeline candidate is supported by the ISID blog source, though this is weaker evidence than the Agent report's identification of Bhutan and Malaysia.

---

## 6. Overall Assessment

### Strengths
1. **Strong base rate analysis:** Three of five forecasters (S1-3, S1-4, S1-5) derived well-calibrated outside views using both Poisson models and empirical window-matched frequencies, arriving at consistent 24.8-37% estimates. The convergence between Poisson (29%) and empirical (27%) lends high confidence.
2. **Excellent self-correction by S2-1:** Forecaster 1 performed a remarkable -40pp correction from its own inflated outside view (67% -> 27%), correctly identifying the absence of current news as strong negative evidence.
3. **Proper negative evidence interpretation:** Four of five forecasters correctly interpreted the absence of 2026 certification announcements as meaningful negative evidence, appropriately adjusting estimates downward.
4. **Effective Agent search:** The agentic search delivered a comprehensive historical certification list with dates and pipeline intelligence in only 3 steps, providing the key quantitative foundation (1.55 certifications/year).

### Weaknesses
1. **Outside view contamination:** S1-1 and S1-2 (both Sonnet 4.5) incorporated pipeline-specific intelligence into their outside views, inflating estimates to 67% and 58%. This violates the two-stage design principle.
2. **GPT-5.2 outlier at 42%:** S2-3 ended 15-20pp above the consensus, driven by insufficient correction of the inflated S1-2 outside view. This outlier pulled the final aggregate upward by ~3pp.
3. **Question URL scrape failure:** The WHO malaria-free certification page (the primary resolution source) failed to scrape.
4. **Low AskNews signal-to-noise ratio:** Many of the 17 AskNews articles were entirely off-topic.

### Overall Quality Grade

| Grade | Criteria |
|-------|----------|
| A | Excellent research, sound reasoning, appropriate calibration, no major errors |
| B | Good overall, minor issues in reasoning or evidence handling |
| C | Adequate, notable weaknesses but core reasoning intact |
| D | Below standard, significant reasoning or factual issues |
| F | Poor, major errors, unreliable output |

**This Forecast Grade: B+**

Reasoning: Strong quantitative base rate analysis with good convergence across models. The Agent research delivered high-value output. Four of five forecasters arrived at a well-calibrated 22-27% range. Downgraded from A due to: (1) outside view contamination in S1-1 and S1-2, (2) one significant outlier (S2-3 at 42%) that lacked strong justification, (3) failed question URL scrape. The pipeline's self-correction mechanism (S2-1's -40pp adjustment) partially compensated for the outside view contamination, demonstrating robustness.

---

## 7. Recommendations

### Research Improvements
- **Fix Question URL scraping for WHO pages:** The WHO malaria-free certification page is the primary resolution source and should be scraped successfully.
- **Filter irrelevant AskNews articles:** Implement relevance filtering before including AskNews results in the research context.
- **Add TAG-MEC meeting schedule search:** For questions about WHO certification timing, explicitly search for the TAG-MEC meeting schedule.

### Prompt/Pipeline Improvements
- **Enforce outside/inside view separation:** The outside view prompt should include stronger language discouraging use of specific pipeline intelligence. S1-1 and S1-2's contamination weakened the two-stage design.
- **Add outlier detection before aggregation:** S2-3's 42% was 15-20pp above all other forecasters. A simple outlier detection mechanism could prompt a review or down-weighting.

### Model-Specific Feedback
- **Sonnet 4.5 (Forecasters 1-2):** Tendency to contaminate outside views with inside-view intelligence. However, excellent self-correction capability in the inside view stage.
- **GPT-5.2 (Forecaster 3):** Best outside view (S1-3 at 24.8%) but worst inside view (S2-3 at 42%). May be susceptible to anchoring bias on received cross-pollinated inputs.
- **o3 (Forecasters 4-5):** Consistently strong and well-calibrated across both stages. Most reliable model in this forecast.

---

## 8. Comparison Flags

| Flag | Value | Notes |
|------|-------|-------|
| Output spread >30pp (binary) | No | Spread is 20pp (22% to 42%) |
| Update direction errors | No | All updates were downward, consistent with negative evidence |
| Factual errors present | Yes | S2-4 cited Belize as pipeline candidate despite it being certified in 2023 |
| Hallucinations detected | No | |
| Cross-pollination effective | Partial | S2-4 received well-calibrated S1-3; S2-3 anchored too heavily on inflated S1-2 |
| Critical info missed in research | Yes | WHO page scrape failed; TAG-MEC meeting schedule not found |
| Base rate calculation errors | No | Poisson and empirical calculations were consistent and well-executed |
| Outlier output (>1.5 SD) | Yes | S2-3 at 42% is ~2 SD above the mean of the other four (24.75%) |

---

## Appendix: Raw Data

### Probability Summary

```
Step 1 Outputs (Outside View):
  S1-1 (Sonnet 4.5): 67%
  S1-2 (Sonnet 4.5): 58%
  S1-3 (GPT-5.2):    24.8%
  S1-4 (o3):         37%
  S1-5 (o3):         26%

Step 2 Outputs (Inside View):
  S2-1 (Sonnet 4.5): 27% (received S1-1, delta: -40pp)
  S2-2 (Sonnet 4.5): 25% (received S1-4, delta: -12pp)
  S2-3 (GPT-5.2):    42% (received S1-2, delta: -16pp)
  S2-4 (o3):         22% (received S1-3, delta: -2.8pp)
  S2-5 (o3):         25% (received S1-5, delta: -1pp)

Final Aggregated: 28.2%
```

### Key Dates
- Forecast generated: 2026-02-10
- Question opens: 2026-02-10 09:00 UTC
- Question closes: 2026-02-10 10:30 UTC
- Question resolves: 2026-05-01
- Forecast window: 80 days (Feb 10 - May 1, 2026)
- Key reference dates from research:
  - Georgia certified: Feb 6, 2025
  - Suriname certified: June/July 2025
  - Timor-Leste certified: July 24, 2025
  - WHO 2025 World Malaria Report released: Dec 4, 2025

---

## Post-Resolution Analysis (Complete After Resolution)

| Field | Value |
|-------|-------|
| Actual Outcome | |
| Final Prediction | 28.2% |
| Peer Score | +20.3 |

### Retrospective
- TBD after resolution
